There's been a string of positive vaccine research news in the past weeks, but keep this in mind: It will take months before populations can be vaccinated on a scale that will start curbing the COVID-19 pandemic.
U.K.-based drugmaker AstraZeneca said on Monday that the coronavirus vaccine it is developing with the University of Oxford had shown an average efficacy of...
Read: AstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials showThe outlook: The announcement adds to the string of positive medical news coming from research laboratories and drug companies in the past weeks, and will brighten the Christmas season for households and businesses. But it will take months before populations can be vaccinated on a scale that will start curbing the COVID-19 pandemic.
Expect another few months of COVID restrictions and lockdowns, especially if a third wave of the pandemic is triggered in early January by the easing of the Christmas season and changes of behavior caused by rising optimism about the many vaccines’ efficacy.Read more: MarketWatch »
Larry King, legendary talk show host, dies at 87
Larry King, the longtime CNN host who became an icon through his interviews with countless newsmakers and his sartorial sensibilities, has died. He was 87.
People aren't gonna want the second dose.. The effects are not forecasted to be appealing on first dose..